Heparin-induced thrombocytopenia type II

Clinical trials for Heparin-induced thrombocytopenia type II explained in plain language.

Never miss a new study

Get alerted when new Heparin-induced thrombocytopenia type II trials appear

Sign up with your email to follow new studies for Heparin-induced thrombocytopenia type II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

New blood thinner tested for rare clotting disorder

Disease control Completed

This study looked at how well the drug argatroban works in 20 adults with a condition called heparin-induced thrombocytopenia Type II, where the blood thinner heparin causes low platelets and raises clot risk. Participants received argatroban to prevent new or worsening blood clo…

Matched conditions: HEPARIN-INDUCED THROMBOCYTOPENIA TYPE II

Phase 2 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control

Last updated Jun 27, 2026 08:09 UTC

Heparin-induced thrombocytopenia type II

Get alerted when new Heparin-induced thrombocytopenia type II trials appear

New blood thinner tested for rare clotting disorder